Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Insulin-like growth factor-1 gene therapy - Valentis

Drug Profile

Insulin-like growth factor-1 gene therapy - Valentis

Alternative Names: IGF-1 gene therapy - Valentis; Somatomedin-1 gene therapy - Valentis

Latest Information Update: 31 Aug 2007

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Valentis
  • Class Antihyperglycaemics; Gene therapies; Growth factors
  • Mechanism of Action Gene transference; Insulin-like growth factor I stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetic neuropathies; Genitourinary disorders; Postmenopausal osteoporosis

Most Recent Events

  • 03 Feb 2003 A preclinical study has been added to the Genitourinary disorders pharmacodynamics section
  • 22 Jun 1999 The merged company of GeneMedicine and Megabios is now called Valentis
  • 29 Mar 1999 GeneMedicine has merged with Megabios
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top